1-naphthylisothiocyanate has been researched along with Short Bowel Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haber, MM; Katz, MS; Schwartz, MZ; Thatch, KA | 1 |
| Bejar, J; Hayari, L; Mogilner, JG; Pollak, Y; Razon, H; Sukhotnik, I; Sylvester, KG | 1 |
2 other study(ies) available for 1-naphthylisothiocyanate and Short Bowel Syndrome
| Article | Year |
|---|---|
Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
Topics: 1-Naphthylisothiocyanate; Animals; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Disease Models, Animal; Female; Hepatocyte Growth Factor; Immunohistochemistry; In Situ Nick-End Labeling; Interleukin-6; Liver; Liver Diseases; Liver Failure; Liver Function Tests; Parenteral Nutrition, Total; Rats; Rats, Sprague-Dawley; Short Bowel Syndrome; Tumor Necrosis Factor-alpha | 2010 |
Effect of alpha-naphthylisothiocyanate-induced liver injury on intestinal adaptation in a rat model of short bowel syndrome.
Topics: 1-Naphthylisothiocyanate; Adaptation, Physiological; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cell Proliferation; Chemical and Drug Induced Liver Injury; Disease Models, Animal; DNA; Enterocytes; Gene Expression Regulation; Intestine, Small; Male; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Short Bowel Syndrome | 2012 |